ABDDF yields 0.73% · JNJ yields 2.14%● Live data
📍 ABDDF pulled ahead of the other in Year 1
Combined, ABDDF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABDDF + JNJ for your $10,000?
AB Dynamics plc, through its subsidiaries, engages in the design, development, manufacture, and supply of vehicle test and development systems, and verification products and services for advanced driver assistance systems (ADAS), autonomous vehicle technology, and vehicle dynamics in the United Kingdom, Germany, the United States of America, China, Japan, Singapore, and internationally. The company offers advanced vehicle testing solutions from physical proving ground automation to large scale virtual testing in simulation; rFpro, a simulation environment for the automotive and motorsport industries; and full-scale track testing services, including ADAS and vehicle dynamics tests, along with applied research, human factors, and simulation. It also provides automotive testing services comprising evaluations of ADAS systems, infotainment, connectivity, electric vehicle performance and charging, and other associated functions; and retrofit solutions that enable the automation of conventional vehicle fleets rapidly and cost-effectively. In addition, the company creates and deploys a range of Driver-in-the-Loop (DIL) simulators for all types of vehicles, driving scenarios, experiments, and product development aims; supplies end-to-end simulation solutions, such as hardware, software, application consultancy, training, and aftermarket support; and advanced vehicle testing solutions from physical proving ground automation to virtual testing in simulation. Its products are used to evaluate vehicle dynamics, noise, vibration, and harshness and autonomy for a range of applications comprise conventional vehicles, motorsport, and automated/autonomous vehicles. The company was founded in 1982 and is headquartered in Bradford-on-Avon, the United Kingdom.
Full ABDDF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.